Skip to content

Clinical trials

Phase 1/2 Neoplasm Metastasis trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Phase: Phase 1/2 Country / region: Netherlands Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20111
20131
20142
20152
20161
20171
20194
20213
20223
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Active, not recruiting5
Recruiting5
Terminated1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)3
Novartis Pharmaceuticals2
Nuvalent Inc.2
UMC Utrecht2
University Medical Center Groningen2
Array BioPharma1
Ascendis Pharma Oncology Division A/S1
AstraZeneca1
BBB-Therapeutics B.V.1
Edwards Lifesciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis22
Colorectal Neoplasms4
Neoplasms4
Breast Neoplasms3
Carcinoma, Non-Small-Cell Lung3
Endometrial Neoplasms3
Esophageal Neoplasms3
Lung Neoplasms3
Neoplasms by Site2
Ovarian Neoplasms2

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.